A one-holding, high-octane bet on biotech: 100% in LABU, a 3× leveraged biotech ETF, checked daily. No diversification or timing. Expect big swings; suited to short-term trading rather than a steady long‑term hold.

Every trading day, the portfolio puts 100% into LABU. LABU is a fund that targets 3× the daily move of a broad U.S. biotech stock index (equal‑weight, heavy in mid/small biotechs). There’s no timing or hedge. Daily reset magnifies moves and can compound gains/losses. Expect very high volatility.

Out-of-sample edge: ~45.8% annualized return vs ~20.4% for SPY, but with far higher volatility and drawdowns (~63% vs ~19%). A high-octane biotech levered bet offering explosive upside in uptrends; not a long-term hold.